ZA897966B - Method for controlling and/or lowering serum triglyceride and/or chollesterol levels in mammals - Google Patents
Method for controlling and/or lowering serum triglyceride and/or chollesterol levels in mammalsInfo
- Publication number
- ZA897966B ZA897966B ZA897966A ZA897966A ZA897966B ZA 897966 B ZA897966 B ZA 897966B ZA 897966 A ZA897966 A ZA 897966A ZA 897966 A ZA897966 A ZA 897966A ZA 897966 B ZA897966 B ZA 897966B
- Authority
- ZA
- South Africa
- Prior art keywords
- controlling
- 10alkyl
- hydrogen
- straight
- chollesterol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/260,947 US4920123A (en) | 1988-10-21 | 1988-10-21 | Method for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA897966B true ZA897966B (en) | 1990-08-29 |
Family
ID=22991313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA897966A ZA897966B (en) | 1988-10-21 | 1989-10-20 | Method for controlling and/or lowering serum triglyceride and/or chollesterol levels in mammals |
Country Status (9)
Country | Link |
---|---|
US (1) | US4920123A (ko) |
EP (1) | EP0370987B1 (ko) |
JP (1) | JP2840089B2 (ko) |
KR (1) | KR900005981A (ko) |
AT (1) | ATE99936T1 (ko) |
AU (1) | AU616313B2 (ko) |
CA (1) | CA2001171C (ko) |
DE (2) | DE370987T1 (ko) |
ZA (1) | ZA897966B (ko) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5110817A (en) * | 1988-10-21 | 1992-05-05 | Beyer Jr Karl H | Method for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals |
US5268181A (en) * | 1989-04-13 | 1993-12-07 | Upsher-Smith Laboratories, Inc. | Method of using niacin to control nocturnal cholesterol synthesis |
US5622985A (en) * | 1990-06-11 | 1997-04-22 | Bristol-Myers Squibb Company | Method for preventing a second heart attack employing an HMG CoA reductase inhibitor |
US6676967B1 (en) * | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
US6080428A (en) | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
US20060263428A1 (en) * | 1993-09-20 | 2006-11-23 | Eugenio Cefali | Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics |
US6129930A (en) | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
US6369103B1 (en) * | 1994-01-18 | 2002-04-09 | Bristol-Myers Squibb Company | Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor |
US5801177A (en) * | 1995-12-14 | 1998-09-01 | Beyer, Jr.; Karl H. | Method for controlling and/or lowering serum glucose and fatty acid concentrations and hypertensive blood pressure in non-insulin-dependent diabetic patients |
DE19622222A1 (de) * | 1996-06-03 | 1997-12-04 | Hoechst Ag | Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide |
GT199800127A (es) | 1997-08-29 | 2000-02-01 | Combinaciones terapeuticas. | |
MX2007002277A (es) | 2004-08-24 | 2007-07-10 | Uab Research Foundation | Metodos para formar retinoides y usos de los mismos. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3274191A (en) * | 1963-11-15 | 1966-09-20 | Merck & Co Inc | N-(3-aminopyrazinoyl) benzamidines and process for preparing |
US4594349A (en) * | 1982-01-04 | 1986-06-10 | Beyer Jr Karl H | Hyperuretic agents |
US4604394A (en) * | 1984-10-01 | 1986-08-05 | Merck & Co., Inc. | Antiarrhythmic compositions and method |
GB8712368D0 (en) * | 1987-05-26 | 1987-07-01 | Erba Farmitalia | Pyrazine n-oxide derivatives |
-
1988
- 1988-10-21 US US07/260,947 patent/US4920123A/en not_active Expired - Lifetime
-
1989
- 1989-10-17 AU AU42909/89A patent/AU616313B2/en not_active Expired
- 1989-10-19 JP JP1272755A patent/JP2840089B2/ja not_active Expired - Fee Related
- 1989-10-20 AT AT89870154T patent/ATE99936T1/de not_active IP Right Cessation
- 1989-10-20 EP EP89870154A patent/EP0370987B1/en not_active Expired - Lifetime
- 1989-10-20 DE DE198989870154T patent/DE370987T1/de active Pending
- 1989-10-20 KR KR1019890015107A patent/KR900005981A/ko not_active Application Discontinuation
- 1989-10-20 ZA ZA897966A patent/ZA897966B/xx unknown
- 1989-10-20 DE DE89870154T patent/DE68912284T2/de not_active Expired - Lifetime
- 1989-10-20 CA CA002001171A patent/CA2001171C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2840089B2 (ja) | 1998-12-24 |
CA2001171A1 (en) | 1990-04-21 |
KR900005981A (ko) | 1990-05-07 |
AU4290989A (en) | 1990-04-26 |
EP0370987A3 (en) | 1990-12-19 |
EP0370987A2 (en) | 1990-05-30 |
ATE99936T1 (de) | 1994-01-15 |
JPH02237923A (ja) | 1990-09-20 |
EP0370987B1 (en) | 1994-01-12 |
AU616313B2 (en) | 1991-10-24 |
DE68912284D1 (de) | 1994-02-24 |
CA2001171C (en) | 1999-12-21 |
US4920123A (en) | 1990-04-24 |
DE68912284T2 (de) | 1994-04-28 |
DE370987T1 (de) | 1991-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA897966B (en) | Method for controlling and/or lowering serum triglyceride and/or chollesterol levels in mammals | |
EP1035123A4 (en) | NEW HETEROCYCLIC COMPOUNDS | |
IL68494A0 (en) | Dihydropyridine derivatives,their production and use | |
FI103884B1 (fi) | Menetelmä farmaseuttisesti tehokkaiden guanidinokarbonyylisubstituoitujen isokinoliinien valmistamiseksi | |
PL267913A1 (en) | Method for manufacturing new derivatives of phenylalkylamines | |
PH24139A (en) | Method of treating anxiety with tetrahydrobenzy(c,d)indole-6-carboxamides | |
NO161564C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater. | |
GR3006490T3 (ko) | ||
ATE63541T1 (de) | N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel. | |
WO1986007059A3 (en) | Oxodiazine compounds | |
ES8505993A1 (es) | Un metodo para preparar un derivado de 3-indolcarboxamida | |
DK360388A (da) | Laegemiddel til behandling af hjerteinsufficiens | |
TW260658B (ko) | ||
ATE132748T1 (de) | Verwendung eines dihydropyridins zur verbesserung der blutzirkulation des inneren ohres | |
DE3782235T2 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
EP0323604A3 (en) | A venous extensibility improving and cardiac hypertrophy suppressant agent containing a dihydropyridine compound |